Literature DB >> 8127716

Sp1 is essential for both enhancer-mediated and basal activation of the TATA-less human adenosine deaminase promoter.

M R Dusing1, D A Wiginton.   

Abstract

Tissue-specific expression of the human adenosine deaminase (ADA) gene is mediated by transcriptional activation over a thousand-fold range. Cis-regulatory regions responsible for high and basal levels of activation include an enhancer and the proximal promoter region. While analyses of the T-cell specific enhancer have been carried out, detailed studies of the the promoter region or promoter-enhancer interactions have not. Examination of the promoter region by homology searches revealed six putative Sp1 binding sites. DNase I footprinting showed that Sp1 is able to bind these sites. Deletion analysis indicated that the proximal Sp1 site is required for activation of a reporter gene to detectable levels and that the more distal Sp1 sites further activate the level of expression. Inclusion of an ADA enhancer-containing fragment in these deletion constructions demonstrated that Sp1 sites are also essential for enhancer function. Apparently Sp1 controls not only low level expression but is also an integral part of the mechanism by which the enhancer achieves high level ADA expression. Mutagenesis of a potential TBP binding site at base pairs -21 to -26 decreased activity only two-fold indicating that it is not essential for transcriptional activation or enhancement.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8127716      PMCID: PMC307859          DOI: 10.1093/nar/22.4.669

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  64 in total

1.  Adenosine deaminase activity in thymus and other human tissues.

Authors:  A Adams; R A Harkness
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

2.  Multiple SP1 binding sites confer enhancer-independent, replication-activated transcription of HIV-1 and globin gene promoters.

Authors:  N J Proudfoot; B A Lee; J Monks
Journal:  New Biol       Date:  1992-04

3.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

Review 4.  Biochemistry of diseases of immunodevelopment.

Authors:  D W Martin; E W Gelfand
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

5.  In vivo sequence requirements of the SV40 early promotor region.

Authors:  C Benoist; P Chambon
Journal:  Nature       Date:  1981-03-26       Impact factor: 49.962

6.  The SV40 early region TATA box is required for accurate in vitro initiation of transcription.

Authors:  D J Mathis; P Chambon
Journal:  Nature       Date:  1981-03-26       Impact factor: 49.962

Review 7.  Organization and expression of eucaryotic split genes coding for proteins.

Authors:  R Breathnach; P Chambon
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

8.  Identification of regulatory sequences in the prelude sequences of an H2A histone gene by the study of specific deletion mutants in vivo.

Authors:  R Grosschedl; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency.

Authors:  R Hirschhorn; F Martiniuk; F S Rosen
Journal:  Clin Immunol Immunopathol       Date:  1978-03

10.  Deletions covering the putative promoter region of early mRNAs of simian virus 40 do not abolish T-antigen expression.

Authors:  C Benoist; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

View more
  11 in total

1.  Characterization of the rat mdr2 promoter and its regulation by the transcription factor Sp1.

Authors:  P C Brown; J A Silverman
Journal:  Nucleic Acids Res       Date:  1996-08-15       Impact factor: 16.971

2.  Characterization of the TATA-less core promoter of the cell cycle-regulated cdc25C gene.

Authors:  K Körner; L A Wolfraim; F C Lucibello; R Müller
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

3.  Conservation of glutamine-rich transactivation function between yeast and humans.

Authors:  D Escher; M Bodmer-Glavas; A Barberis; W Schaffner
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  Characterization of the mouse myeloid-associated differentiation marker (MYADM) gene: promoter analysis and protein localization.

Authors:  Karin Dannaeus; Marina Bessonova; Jan-Ingvar Jönsson
Journal:  Mol Biol Rep       Date:  2005-09       Impact factor: 2.316

5.  Sp1-mediated transactivation of LamC1 promoter and coordinated expression of laminin-gamma1 and Sp1 in human hepatocellular carcinomas.

Authors:  J Liétard; O Musso; N Théret; A L'Helgoualc'h; J P Campion; Y Yamada; B Clément
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

6.  Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1.

Authors:  David M Cauvi; Gabrielle Cauvi; K Michael Pollard
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

Review 7.  Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?

Authors:  Benjamin Hall; Jonathan G George; Scott P Allen
Journal:  Histol Histopathol       Date:  2021-12-09       Impact factor: 2.303

8.  Regulation of expression of the stress response gene, Osp94: identification of the tonicity response element and intracellular signalling pathways.

Authors:  Ryoji Kojima; Jeffrey D Randall; Eri Ito; Hiroyuki Manshio; Yoshio Suzuki; Steven R Gullans
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

9.  Cloning, expression, and functional analysis of rat liver cytosolic inorganic pyrophosphatase gene and characterization of its functional promoter.

Authors:  Harekrushna Panda; Ravi S Pandey; Priya R Debata; Prakash C Supakar
Journal:  Gene Expr       Date:  2007

10.  A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis.

Authors:  J M Heckmann; H Uwimpuhwe; R Ballo; M Kaur; V B Bajic; S Prince
Journal:  Genes Immun       Date:  2009-08-13       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.